ipilimumabnivolumabDNAJ-PKAcFibrolamellar carcinoma (FLC)Johns Hopkins IRBT Cell Receptor (TCR)-Based cellular therapy
…combination with the immune checkpoint inhibitors nivolumab and ipilimumab. We analyzed PBMCs from a subset of patients who demonstrated a…